BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27218288)

  • 1. Shielding Design for Adjacent, Underground Buildings of a Megavoltage Radiotherapy Facility.
    Sanz DE
    Health Phys; 2016 Jul; 111(1):1-10. PubMed ID: 27218288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculations of neutron and photon source terms and attenuation profiles for the generic design of the SPEAR3 storage ring shield.
    Rokni SH; Khater H; Liu JC; Mao S; Vincke H
    Radiat Prot Dosimetry; 2005; 115(1-4):200-6. PubMed ID: 16381712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose reduction of scattered photons from concrete walls lined with lead: Implications for improvement in design of megavoltage radiation therapy facility mazes.
    Al-Affan IA; Hugtenburg RP; Bari DS; Al-Saleh WM; Piliero M; Evans S; Al-Hasan M; Al-Zughul B; Al-Kharouf S; Ghaith A
    Med Phys; 2015 Feb; 42(2):606-614. PubMed ID: 28102603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shielding design of an underground experimental area at point 5 of the CERN Super Proton Synchrotron (SPS).
    Mueller MJ; Stevenson GR
    Radiat Prot Dosimetry; 2005; 115(1-4):181-6. PubMed ID: 16381709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry validation of treatment room shielding design.
    Stathakis S; Price R; Ma CM
    Med Phys; 2005 Feb; 32(2):448-54. PubMed ID: 15789591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of radiation shielding for the proton therapy facility at the National Cancer Center in Korea.
    Kim JW; Kwon JW; Lee J
    Radiat Prot Dosimetry; 2005; 115(1-4):271-5. PubMed ID: 16381727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shielding for the upgraded Duke Free Electron Laser Laboratory.
    Vylet V
    Radiat Prot Dosimetry; 2005; 115(1-4):207-11. PubMed ID: 16381713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target station shielding issues at the spallation neutron source.
    Ferguson PD; Gallmeier FX; Iverson EB; Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):170-5. PubMed ID: 16381707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo simulations for the design of the treatment rooms and synchrotron access mazes in the CNAO Hadrontherapy facility.
    Porta A; Agosteo S; Campi F
    Radiat Prot Dosimetry; 2005; 113(3):266-74. PubMed ID: 15713741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for establishing shielding of multi-detector computed tomography (MDCT) rooms.
    Verdun FR; Aroua A; Baechler S; Schmidt S; Trueb PR; Bochud FO
    Radiat Prot Dosimetry; 2010; 139(1-3):403-9. PubMed ID: 20215444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCNPX vs. DORT for SNS shielding design studies.
    Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):559-63. PubMed ID: 16381785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shielding evaluation and acceptance testing of a prefabricated, modular, temporary radiation therapy treatment facility.
    Ezzell GA
    J Appl Clin Med Phys; 2004; 5(4):120-5. PubMed ID: 15738926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculations for the availability of photoneutron using synchrotron radiation.
    Asano Y; Kawashima Y
    Radiat Prot Dosimetry; 2005; 115(1-4):176-80. PubMed ID: 16381708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum dose angle for oblique incidence on primary beam protective barriers in the design of medical radiation therapy facilities.
    Fondevila D; Arbiser S; Sansogne R; Brunetto M; Dosoretz B
    Med Phys; 2008 May; 35(5):1816-9. PubMed ID: 18561656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beam dumps design and local radiation protection at TERA synchrotron.
    Porta A; Campi F; Agosteo S
    Radiat Prot Dosimetry; 2005; 115(1-4):222-6. PubMed ID: 16381716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose reduction of scattered photons from concrete walls lined with lead: Implications for improvement in design of megavoltage radiation therapy facility mazes.
    Al-Affan IA; Hugtenburg RP; Bari DS; Al-Saleh WM; Piliero M; Evans S; Al-Hasan M; Al-Zughul B; Al-Kharouf S; Ghaith A
    Med Phys; 2015 Feb; 42(2):606-14. PubMed ID: 25771559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shielding design for the PANDA spectrometer at the Munich high-flux reactor FRM-II.
    Noack K; Pyka NM; Rogov A; Steichele E
    Radiat Prot Dosimetry; 2005; 115(1-4):262-7. PubMed ID: 16381725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shielding variation effects for 250 MeV protons on tissue targets.
    Brandl A; Hranitzky C; Rollet S
    Radiat Prot Dosimetry; 2005; 115(1-4):195-9. PubMed ID: 16381711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary shielding assessment for the 100 MeV proton linac (KOMAC).
    Lee YO; Cho YS; Chang J
    Radiat Prot Dosimetry; 2005; 115(1-4):569-72. PubMed ID: 16381787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the shielding for an unoccupied roof of a radiation therapy facility to account for adjacent buildings--modification of a computer program.
    Biggs PJ
    Health Phys; 1998 Oct; 75(4):431-5. PubMed ID: 9753370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.